On a year-on-year (YoY) basis, Mastek's net profit declined 11.93%, while revenue rose 16.11% in Q4 FY25.

Operating EBITDA stood at Rs 138.8 crore in the March quarter, registering a decline of 1.4% QoQ and a growth of 10.9% YoY. The operating EBITDA margin reduced to 15.3% in Q4 FY25, compared to 16.2% in Q3 FY25 and 16.0% in Q4 FY24.

In terms of dollars, the firm's revenue was $104.6 million in Q4 FY25, up 1.7% QoQ and 11.6% YoY. In constant currency terms, revenue was up by 2.9% QoQ and 12.3% YoY.

The 12-month order backlog was Rs 2,290.9 crore ($264.5 million) as of 31 March 2025, as compared to Rs 2,168.4 crore ($260.0 million) in Q4 FY24, reflecting growth of 5.6% in rupee terms and 0.3% in constant currency terms on a Y-o-Y basis, and Rs 2,138.7 crore ($249.8 million) in Q3 FY25, reflecting growth of 7.1% in rupee terms and 3.8% in constant currency terms on a Q-o-Q basis.

The total cash, cash equivalents, and fair value of mutual funds stood at Rs 622.2 crore as of 31st March 2025, as compared to Rs 497 crore as of 31st December 2024.

The company added 11 new clients in Q4 FY25. Total active clients during Q4 FY25 were 348 as compared to 351 in Q3 FY25.

As of 31st March, 2025, the company had a total of 5,058 employees, of which 3,456 employees were based offshore in India, while the rest were at various onsite locations. Employee count at the end of 31st December, 2024, was 5,260. Last twelve months attrition at 19.3% in Q4FY25 in comparison with 20.1% in Q3 FY25.

On a full-year basis, the company’s consolidated net profit jumped 25.18% to Rs 375.93 crore on a 13.10% increase in revenue to Rs 3,455.23 crore in FY25 over FY24.

Umang Nahata, chief executive officer, Mastek, said, “We are pleased to report a steady performance in Q4FY25, delivering a revenue growth of 4.1% Q-o-Q and 16.1% Y-o-Y in rupee terms. We closed FY24-25 with strong annual revenue and PAT growth of 13.1% and 20.9%, respectively, in rupee terms, driven by disciplined execution across geographies and innovation across all service lines.

We continue to enhance our Data & AI capabilities across verticals, with a focused go-to-market approach targeting Fortune 1000 clients. Our 12-month order backlog grew by 7.1% Q-o-Q, reflecting strong order book performance sustained by demand for our digital engineering, cloud, and data & AI services.

Our core business, driven by UK & Europe and Oracle in US continues to grow strongly, particularly in the healthcare and commercial sectors. The UK healthcare and secured government services continue to show strong momentum, supported by the government’s 10- year modernization plan and increased investments in AI and data.

With strong cash & cash equivalents of Rs 622.2 crore in Q4 FY25, we remain committed to operational efficiency and margin improvement. While macroeconomic uncertainties persist, our sharp execution focus and deep client partnerships positions Mastek for sustainable and profitable growth in FY26 and beyond.”

Meanwhile, the company’s board has recommended a final dividend of Rs 16 per equity share for the financial year ended 31 March 2025, subject to shareholders’ approval at the upcoming 43rd Annual General Meeting. The dividend will be paid within 30 days of approval.

Mastek is an IT company providing enterprise digital and cloud transformation services to the government/public sector, health and life sciences, retail and financial service sectors. The company's service offering includes, application development, Oracle suite & cloud migration, digital commerce, application support & maintenance, BI & analytics, assurance & testing and agile consulting.

The scrip shed 0.27% to end at Rs 2,328.10 on Thursday, 17 April 2025.